Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001214659-20-002746)

Filing Details

Accession Number:: 0001214659-20-002746
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-18 16:45:20
Reporting Period:: 2020-03-16

Accepted Time:: 2020-03-18 16:45:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1398733	Aquestive Therapeutics Inc.	AQST	Pharmaceutical Preparations (2834)	208623253

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1739816	E. Peter Boyd	C/O Aquestive Therapeutics, Inc. 30 Technology Drive Warren NJ 07059	Svp-Bus. Process & Info. Tech.	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-16	2,000	$1.50	52,239	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Acquisiton	2020-03-16	50,700	$0.00	50,700	$1.54

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
50,700		2030-03-16	No	4	A	Direct

Footnotes

The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries.